← FDA Drug Approvals (Drugs@FDA)

IRBESARTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2012-11-14

Drug application

FDA Application #

ANDA077205

Application type

Abbreviated New Drug Application (Generic)

Brand name

IRBESARTAN

Generic name

IRBESARTAN

Active ingredients

IRBESARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2012-11-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown